STOCK TITAN
  1. Home
  2. Sec-filings
  3. KRMD
  4. [Form 4] KORU Medical Systems, Inc. Insider Trading Activity

KRMD (KRMD) insider entities tied to Joseph Manko update share holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

KORU Medical Systems, Inc. insider entities associated with director and 10% owner Joseph M. Manko Jr. reported several transactions in common stock on February 13, 2026, all at a reported price of $0 per share under transaction code J.

After these transactions, Horton Capital Partners Fund, LP indirectly held 5,062,498 shares, Horton Capital Partners, LLC indirectly held 750,000 shares, and Manko directly held 782,547 shares. The filing emphasizes that it should not be construed as an admission of beneficial ownership of the reported securities.

Positive

  • None.

Negative

  • None.
Insider Manko Joseph M. Jr., Horton Capital Management, LLC, Horton Capital Partners, LLC, Horton Capital Partners Fund, L.P.
Role Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner
Type Security Shares Price Value
Other Common Stock 770,418 $0.00 --
Other Common Stock 750,000 $0.00 --
Other Common Stock 750,000 $0.00 --
Other Common Stock 282,347 $0.00 --
Holdings After Transaction: Common Stock — 5,062,498 shares (Indirect, By Horton Capital Partners Fund, LP); Common Stock — 782,547 shares (Direct)
Footnotes (1)
  1. See Exhibit 99.1 to this Form 4 for explanation of note (1). See Exhibit 99.1 to this Form 4 for explanation of note (2). See Exhibit 99.1 to this Form 4 for explanation of note (3). See Exhibit 99.1 to this Form 4 for explanation of note (4).
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Manko Joseph M. Jr.
(Last) (First) (Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PA 19103
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/13/2026 J(1) 770,418 D $0 5,062,498 I By Horton Capital Partners Fund, LP(4)
Common Stock 02/13/2026 J(2) 750,000 A $0 750,000 I By Horton Capital Partners, LLC(4)
Common Stock 02/13/2026 J(2) 750,000 D $0 0 I By Horton Capital Partners, LLC(4)
Common Stock 02/13/2026 J(3) 282,347 A $0 782,547 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
Manko Joseph M. Jr.
(Last) (First) (Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PA 19103
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Horton Capital Management, LLC
(Last) (First) (Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PA 19103
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Horton Capital Partners, LLC
(Last) (First) (Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PA 19103
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Horton Capital Partners Fund, L.P.
(Last) (First) (Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PA 19103
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. See Exhibit 99.1 to this Form 4 for explanation of note (1).
2. See Exhibit 99.1 to this Form 4 for explanation of note (2).
3. See Exhibit 99.1 to this Form 4 for explanation of note (3).
4. See Exhibit 99.1 to this Form 4 for explanation of note (4).
Remarks:
The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.
/s/ Joseph M. Manko, Jr. 02/13/2026
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Management, LLC 02/13/2026
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC 02/13/2026
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC, the General Partner of Horton Capital Partners Fund, LP 02/13/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions in KRMD stock were reported on February 13, 2026?

Insider entities linked to Joseph M. Manko Jr. reported several code J transactions in KORU Medical Systems common stock on February 13, 2026, all at a stated price of $0 per share. These transactions adjusted reported holdings across direct and indirect ownership positions.

How many KRMD shares does Horton Capital Partners Fund, LP report holding?

Following the February 13, 2026 transactions, Horton Capital Partners Fund, LP reported indirect beneficial ownership of 5,062,498 KORU Medical Systems common shares. This position is reported through Form 4 and reflects its status as a 10% owner of KRMD.

What is Horton Capital Partners, LLC’s reported ownership in KRMD?

After the reported February 13, 2026 transactions, Horton Capital Partners, LLC reported indirect beneficial ownership of 750,000 KORU Medical Systems common shares. These holdings are disclosed on Form 4, reflecting its role as a 10% owner of KRMD stock.

How many KRMD shares does Joseph M. Manko Jr. directly own after these transactions?

Joseph M. Manko Jr. reported direct beneficial ownership of 782,547 KORU Medical Systems common shares after the February 13, 2026 transactions. He is identified as both a director and a 10% owner in the filing’s reporting person information.

What does transaction code J mean in the KRMD Form 4 filing?

The KRMD Form 4 uses transaction code J for the reported common stock movements, indicating an "other" type of transaction. All such entries show a reported price of $0 per share, with details and explanations referenced in accompanying Exhibit 99.1.

Do the KRMD insiders admit beneficial ownership of all reported shares?

The filing states it should not be construed as an admission that the reporting persons are beneficial owners of the equity securities covered. It clarifies that the statement is not a legal admission of beneficial ownership under Section 16 of the Exchange Act.